NCT00314782 - Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2009

Conditions

Prostate Cancer

Interventions

DRUG

ZD4054 (Zibotentan)

oral tablet

DRUG

Docetaxel

intravenous infusion

DRUG

Placebo

Trial Locations (9)

Research Site, Buffalo

Research Site, Greenville

Research Site, Nashville

Research Site, Berlin

Research Site, Dresden

Research Site, Rostock

Research Site, London

Research Site, Plymouth

Research Site, Surrey